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BIOFILM-ASSOCIATED STAPHYLOCOCCUS AUREUS VIABILITY 
IS ALTERED BY BURKHOLDERIA CENOCEPACIA
Bridget Wall, Tiffany J. Brandt, Deborah Yoder-Himes, Ph.D
University of Louisville, Department of Biology
BACKGROUND
Respiratory failure caused by chronic and recurrent microbial infections is 
the most common cause of death for people with cystic fibrosis (CF)1, a 
disease causing the formation of thick mucus in the lungs2. Most bacteria 
can form biofilms, collections of sessile cells adhered to a surface by a 
secreted substance. Biofilm-associated cells develop antibiotic resistance at 
higher rates3. The thicker mucus in CF lungs is extremely difficult to clear 
via action of the mucociliary escalator and its presence fosters the 
formation of bacterial biofilms. Staphylococcus aureus and Burkholderia
cenocepacia are two pathogens commonly found in the CF lung. Previous 
work in the Yoder-Himes laboratory established an antagonistic relationship 
between members of the B. cepacia complex and S. aureus biofilms4. To 
understand this antagonism, it is crucial to identify the biofilm changes 
occurring when S. aureus and B. cenocepacia interact. This work provides 
insight into the changes that may be responsible for the reduced viability of
S. aureus in biofilms. Using crystal violet to measure biofilm biomass, 
confocal laser scanning microscopy, and assessing differences in antibiotic 
susceptibility, S. aureus and B. cenocepacia were examined in both 
monoculture and co-culture conditions. The results of this experiment 
indicate S. aureus and B. cenocepacia biofilm formation increases over time 
and is greater in nutrient-rich media. Additionally, B. cenocepacia inhibits 
biofilm formation of S. aureus. These findings provide information that can 
be used for understanding the interactions between pathogenic bacteria in 
the lungs of CF patients, leading to the development of more effective 
therapeutics.
RESULTS
I. Crystal Violet assay to measure biofilm biomass
i. Mid-logarithmic phase cultures were diluted into LB, TSB, 1% TSB, SCFSM, 
and M9 minimal medium supplemented with glucose and casamino acids. 
Dilutions of 106 CFU/mL were inoculated into a 96-well plate in 5 replicate 
wells per condition. 
ii. After incubation at 37°C for 3, 5, or 7 days, the plates were washed and 
stained with 0.1% crystal violet.
iii. The stain was homogenized with 30% acetic acid and absorbances 
corresponding to total biomass were read using a spectrophotometer.
II. Confocal Laser Scanning Microscopy
i. Mid-logarithmic phase cultures were diluted into TSB + glucose or SCFSM at 
106 CFU/mL and mono- and co-culture conditions were inoculated in 
triplicate into 8-well chamber slides.
ii. Chamber slides were incubated at 37°C for 3 or 7 days.
iii. Biofilms were fixed with 1% formaldehyde and imaged using Nikon NIS-
Element software and CLSM. Fluorescence was detected using GFP (487 nm) 
and TxRed (561 nm) lasers.
III. Antibiotic susceptibility assay
i. Mid-logarithmic phase cultures were diluted into LB + glucose to 106 CFU/mL 
and inoculated into triplicate wells of a 96-well plate.
ii. After incubation at 37°C for 1, 3, and 7 days, biofilms were treated with 
Vancomycin at 0, 0.5, 1.5, and 5.0 g/mL.
iii. Biofilms were then sonicated to dislodge from 96-well plate surface, serially 
diluted, and plated. After 24 hours incubation, CFU/mL were manually 
counted.
METHODS
CONCLUSIONS AND FUTURE 
DIRECTIONS
I. Biofilm biomass is dependent upon medium 
and co-occurring partner. Biomass does not 
indicate if one species makes up a greater 
proportion of the biofilm. Future work will 
aim to identify species-specific contributions 
to biofilm biomass.
II. Biofilm structure appears different across 
media types and in mono- versus co-culture 
conditions. Artifacts due to fixation method 
did not allow for enough biofilm surface to 
complete statistical analysis. A different 
method of fixation will be used in the future.
III. S. aureus antibiotic resistance did not follow 
a clear trend. This experiment serves as a 
pilot study to standardize growth conditions 
and effective antibiotic concentrations. 
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HYPOTHESIS IIN S. AUREUS BIOFILMS WILL BE STRUCTURALLY DIFFERENT IN MONO-CULTURE VERSUS IN CO-CULTURE WITH 
B. CENOCEPACIA 
Figure 2: Representative images from confocal laser scanning microscopy of 3-day old biofilms indicate differences in 
biofilm formation of mono-culture versus co-culture biofilms. Biofilm structure is different depending on growth medium. 
The presence of B. cenocepacia (red) reduced the presence of S. aureus NRS77 (green) biofilms 3 days post co-inoculation.
Figure 1: Biofilm biomass
was greatest after a 7-day
incubation period. Biofilms
grown in nutrient-rich
media had a greater






* p < 0.05, *** p < 0.001,
**** p < 0.0001. Figure 3. This pilot study did not demonstrate a clear trend in antibiotic resistance of S. aureus. However, this data
supports the multi-strain B. cenocepacia-mediated reductive effect on S. aureus biofilm formation. Statistical
analysis was performed using a 1-Way ANOVA. Asterisks denote statistical significance of co-culture CFU/mL
compared to monoculture CFU/mL: * p < 0.05, *** p < 0.001, **** p < 0.0001.
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HYPOTHESIS III: ANTIMICROBIAL RESISTANCE OF BIOFILM-ASSOCIATED S. AUREUS WILL INCREASE 
AFTER INCUBATION WITH B. CENOCEPACIA
HYPOTHESIS I: THE BIOMASSES OF S. AUREUS AND B. CENOCEPACIA WILL BE LARGER IN NUTRIENT RICH MEDIA AND 
INCREASE OVER TIME. 
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